Entering text into the input field will update the search result below

Vertex defended after setback and Biogen adds another bull at Bernstein; in today’s analyst action

Diagrams projecting from tablet
goir/iStock via Getty Images

Vertex defended across the board despite the setback

  • Vertex Pharmaceuticals (NASDAQ:VRTX) continues to trade lower with a ~14.0% loss in the pre-market on its decision to halt the development of VX-864 for alpha-1 antitrypsin

Recommended For You

Related Stocks

SymbolLast Price% Chg
OGN--
Organon & Co.
OCGN--
Ocugen, Inc.
BIIB--
Biogen Inc.
VRTX--
Vertex Pharmaceuticals Incorporated